[Ganglion-blockers and the digestive tract].
D002317:Cardiovascular Agents; D005767:Gastrointestinal Diseases / Q000628:therapy*; D041981:Gastrointestinal Tract / Q000187:drug effects*; D006801:Humans; D000077771:Methantheline; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012602:Scopolamine Derivatives; D019789:Tetraethylammonium / Q000494:pharmacology*
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D012602:Scopolamine Derivatives; D000077771:Methantheline; D019789:Tetraethylammonium
GASTROINTESTINAL DISEASES/therapy; GASTROINTESTINAL SYSTEM/effect of drugs on; METHANTHELINE/effects; MUSCLE RELAXANTS/effects; PARASYMPATHOLYTICS/effects; SCOPOLAMINE/derivatives; TETRAETHYLAMMONIUM/effects
Ganglioplégiques et voies digestives.